E Europe news briefs

20 March 2006

- Latvia's State Medicines Agency says that the price of medicinal products in the country increased a substantial 40% last year, according to the Baltic Business News. One of the reasons for this was said to be the ending of imports of cheap drugs from Russia. Latvian pharmaceutical wholesalers saw their sales grow 20% year-on-year in 2005.

- Croatia's Bureau of Statistics reports that the country exported medical and pharmaceutical products worth $36.0 million in January, a year-on-year increase of 8%. Croation imports of the same types of commodities in January were 21.9% higher year-on-year, at $43.0 million.

- The authorities in Russia's Chelyabinsk region have said that a working group has been established to examine the possibility of the Hungarian drugmaker, Serbolab, setting up a $30.0 million plant for the production of vaccines in Chelyabinsk, reports the Interfax news agency.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight